Among them, we demonstrated that MKI-2, the most potent MASTL inhibitor [19], markedly increases mitotic cell death and induces spindle defects in HeLa and MCF7 cells, and in a 4T1 breast tumor model. This evidence concerns the gene MASTL and breast neoplasm.